AdobeStock_322725872.jpeg
KODATEF tafenoquine succinate
Kodatef_logo_succinate_RGB.jpg

It is important that you only take this medicine on your doctor’s advice. Please contact your doctor or Healthcare Professional if you have any questions about this medicine or its use. Biocelect does not provide medical advice to patients or consumers. You will find information about your medicine in the Consumer Medicine Information below.

Kodatef is approved for malaria prevention (prophylaxis) when travelling to areas where malaria is present

Kodatef is an antimalarial indicated for the prevention of malaria in adults 18 years of age and above for up to 6 months of continuous dosing.

 

Copies of the Product Information and Consumer Medicine Information are available below.

* Current TGA approved indication in Australia. Kodatef is currently TGA approved in Australia. Kodatef is not approved by MedSafe in New Zealand.

Australia

New Zealand